Ledger.Open graph →
SEC Form D · Amendment · filed August 20, 2024

Ambrosia Biosciences Inc

Offering
$25.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

John S. Orwin · Boulder, CODirectorRichard Baur · St Louis, MODirectorWilliam S. Marshall · Boulder, CODirectorNicholas Traggis · Boulder, COExec · DirectorConner Thomas · SAN FRANCISCO, CAExec · DirectorJohn S. Orwin · Boulder, CODirectorKindal Kreamer · New York, NYDirectorDavid S. Snitman · Boulder, CODirectorWilliam S. Marshall · Boulder, CODirectorDavid S. Snitman · Boulder, CODirectorAlatus Capital LLC · Geneva, V8DirectorKyle J. Lefkoff · Boulder, CODirectorMark D. O'Sullivan · NEW YORK, NYDirectorNicholas Traggis · Boulder, COExec · DirectorDonald J. Rogers · WESTPORT, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗